HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

459.400

+13.6003.05%

Volume:900

Turnover:413.46K

Market Cap:109.80B

PE:-277.28

High:459.400

Open:459.400

Low:459.400

Close:445.800

52wk High:577.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:- -

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.657

ROE:2.92%

ROA:-0.04%

PB:17.57

PE(LYR):-277.28

PS:44.96

Loading ...

Overview Company News Filings

Kelun, Merck's lung cancer combo improves survival in late-stage China trial

Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS

SKB BIO Shares Surge Over 5% on Positive Phase III Results for TROP2 ADC Developed with Merck

Stock Track | SKB BIO Soars 5.22% Intraday on Positive Phase III Trial Results and Regulatory Approval

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.52% in Regular Trading, TROP2 ADC Phase III Trial Achieves Dual Primary Endpoints in Endometrial Cancer

A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After New Oncology Regulatory Milestones

Simply Wall St.

SKB BIO Shares Surge Over 5% in Morning Session on Merck's TROP2 ADC Therapy Phase 3 Success

Sichuan Kelun-Biotech Biopharmaceutical Receives NMPA Approval For IND Application For SKB118 (CR-001)

Sichuan Kelun-Biotech Wins China IND Nod for Cancer Therapy

MT Newswires Live

SKB BIO Receives NMPA Approval for Investigational New Drug Application of SKB118

SKB BIO Secures NMPA Green Light for PD-1/VEGF Bispecific Antibody SKB118; Crescent Biopharma Collaboration Advances Global Development

Bulletin Express

Kelun-Biotech says China regulator clears SKB118 clinical trial application

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Receives Nmpa Approval for Ind Application for Skb118 (Cr-001) for Advanced Solid Tumors

THOMSON REUTERS

SKB Biopharma's Application for New Indication of Tumor Drug Accepted in China

MT Newswires Live

the Snda for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Pembrolizumab as First‑Line Treatment for Pd-L1-Positive Nsclc Accepted for Review by Nmpa

THOMSON REUTERS

SKB BIO's Core TROP2 ADC Therapy Sac-TMT Gains NMPA Acceptance for New Indication Application

Kelun-Biotech sac-TMT plus Keytruda NSCLC application accepted for review by China regulator

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nmpa Accepts New Indication Application for Sacituzumab Tirumotecan (Sac-TMT)

THOMSON REUTERS

3 Asian Stocks That May Be Undervalued In May 2026

Simply Wall St.

SKB BIO Shares Rise Nearly 3% in Late Trading as Three Studies Selected for Oral Presentation at 2026 ASCO Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/06990/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":459.4,"timestamp":1791508818198,"preClose":445.8,"halted":0,"volume":900,"delay":0,"changeRate":0.030506953790937562,"floatShares":177000000,"shares":239000000,"eps":-1.65683,"marketStatus":"Pre-opening","change":13.6,"latestTime":"10-09 09:22:32","open":459.4,"high":459.4,"low":459.4,"amount":413460,"amplitude":0,"askPrice":459.4,"askSize":900,"bidPrice":450,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":0.748354,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":1,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":445.8,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"-0.04%","roe":"2.92%","lyrEps":-1.65683,"shares":239000000,"dividePrice":0,"high":459.4,"amplitude":0,"preClose":445.8,"low":459.4,"week52Low":339.6,"pbRate":"17.57","psRate":"44.96","week52High":577,"institutionHeld":0,"latestPrice":459.4,"committee":0.1,"eps":-1.65683,"divideRate":0,"volume":900,"delay":0,"ttmEps":0.748354,"open":459.4,"prevYearClose":392.2,"fiveDayClose":472.2,"twentyDayClose":474.4,"sixtyDayClose":522.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4348,"buy":0.5652,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5652,"analysts":23,"updateTime":1789056000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-10-08","current":613.880597,"percent":0.955,"low":-351.800852,"twenty":-231.805328,"median":-131.985022,"eighty":-49.231548,"high":737.230287,"avg":-104.758961,"sd":187.332509,"marketCap":106556885380},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322},{"date":"2026-08-28","current":697.321291,"twenty":-236.422847,"median":-135.694724,"eighty":-52.683151,"marketCap":122977832050},{"date":"2026-09-04","current":663.036146,"twenty":-235.974841,"median":-134.724854,"eighty":-51.598494,"marketCap":116978330428},{"date":"2026-09-11","current":629.400754,"twenty":-235.513087,"median":-134.225664,"eighty":-51.109685,"marketCap":111193950378},{"date":"2026-09-18","current":623.71512,"twenty":-235.013451,"median":-133.7999,"eighty":-50.803766,"marketCap":110333464090},{"date":"2026-09-25","current":632.216536,"twenty":-234.402164,"median":-132.867642,"eighty":-50.391843,"marketCap":111624193523},{"date":"2026-10-02","current":638.582944,"twenty":-233.372292,"median":-132.379263,"eighty":-49.875681,"marketCap":112867118161},{"date":"2026-10-08","current":602.129347,"twenty":-231.805328,"median":-131.985022,"eighty":-49.231548,"marketCap":106556885380}],"updateTime":1791508952159},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637520023","title":"Kelun, Merck's lung cancer combo improves survival in late-stage China trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637520023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637520023?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:02","pubTimestamp":1779397340,"startTime":"0","endTime":"0","summary":"Kelun, Merck's lung cancer combo improves survival in late-stage China trialMay 21 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical 6990.HK said on Thursday its experimental treatment combined with","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4N41Y24Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU1023059063.AUD","LU2125154935.USD","LU2361044865.SGD","LU0969580561.USD","LU1116320737.USD","LU0320765646.SGD","LU2468319806.SGD","LU0784385840.USD","LU1496350502.SGD","LU2089984988.USD","LU2237443895.HKD","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4516","LU0889565080.SGD","IE00BN8TJ469.HKD","LU0171276677.USD","LU0106261372.USD","LU1170363599.USD","LU1496350171.SGD","LU1983299246.USD","LU1162221912.USD","LU1196032939.SGD","LU1699723380.USD","LU1066053197.SGD","BK4007","LU1261432733.SGD","LU2433249047.HKD","LU2133065610.SGD","LU0965509101.SGD","LU1064927863.SGD","LU0887340254.USD","LU2360032135.SGD","BK4559","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2125909247.SGD","IE00B2B36J28.USD","LU0985320562.USD","LU1015430645.USD","LU0122379950.USD","LU0859254822.USD","LU1481599808.USD","LU0784385170.HKD","IE00B3T34201.USD","LU0997586432.USD","LU2112291526.USD","LU0972486137.USD","LU0823416689.USD","LU1037948541.HKD","BK0060","LU1323610961.USD","SG9999015341.SGD","LU2237443382.USD","LU0011850046.USD","LU0130102774.USD","LU0047473722.EUR","LU0070302665.USD","LU1923622614.USD","BK4588","LU1267930573.SGD","LU0949170772.SGD","SG9999001176.USD","IE0034235188.USD","LU0792757196.USD","SG9999002224.SGD","LU1267930490.SGD","LU0889566641.SGD","LU1093756325.SGD","IE00BLSP4239.USD","LU2237443549.SGD","LU0575583348.USD","LU0211326755.USD","LU1989772923.USD","LU2023250504.SGD","IE0009355771.USD","LU1084165304.USD","LU1066051811.HKD","LU1291159041.SGD","LU0784383803.USD","LU2293690249.USD","LU0861579265.USD","LU0965509283.SGD","LU2023250843.SGD","03165","LU0738911758.USD","LU0077335932.USD","LU0158827948.USD","LU2237443978.SGD","LU0208291251.USD","LU0942090050.USD","LU0976567544.SGD","LU0052756011.USD","LU1035773651.USD","LU2491050071.SGD","LU0960981461.USD","LU1273509221.SGD","LU0289739699.SGD","LU0868494708.USD","LU2461242641.AUD","IE00BBT3K403.USD","LU0265550359.USD","SG9999014559.SGD","MRK","06990","LU0130517989.USD","SGXZ57979304.SGD","IE00BKPKM643.USD","LU0098860793.USD","LU1116320901.HKD","LU1934455863.HKD","LU0920783379.SGD","IE00B1BXHZ80.USD","LU1880407215.USD","LU0827474353.SGD","LU2125154778.USD","LU0553294199.USD","LU1917777945.USD","LU1069347547.HKD","LU1934453819.USD","LU2106854487.HKD","LU1267930227.SGD","LU0211327993.USD","LU0390134368.USD","LU1929549753.HKD","LU1064130708.USD","LU0058720904.USD","LU1585245621.USD","LU0980610538.SGD","LU0640478417.SGD","LU1119994496.HKD","LU2491050154.USD","BK4533","SG9999014575.USD","LU0477156953.USD","LU2125909593.SGD","LU0965508806.USD","BK4534","LU0266013472.USD","LU1267930813.SGD","LU0432979614.USD","BK4550","SG9999002232.USD","LU0128525689.USD","SG9999014542.SGD","LU0029864427.USD","LU1487256676.USD","LU1019634622.SGD","LU1201861249.SGD","IE0002141913.USD","IE00BSNM7G36.USD","LU2361044949.HKD","LU0957799991.USD","LU2357627491.SGD","LU0114720955.EUR","LU0310800965.SGD","LU1979443071.USD","LU2237443465.HKD","LU0708994859.HKD","LU0545039389.USD","LU0965509010.AUD","LU1003077747.HKD","LU0920840948.USD","LU2293690082.USD","LU2361045086.USD","LU1066051498.USD","LU1051770623.HKD","LU0648001328.SGD","LU1301847155.USD","LU0496365809.HKD","LU1093756168.USD","LU1934455194.USD","LU0211328371.USD","LU0784384876.USD","IE00BJJMRZ35.SGD","LU2023251221.USD","LU1989772840.SGD","IE000M9KFDE8.USD","LU2089283258.USD","LU2355687059.USD","LU1814569148.SGD","LU0345777147.USD","LU0310800379.SGD","LU1430594728.SGD","LU0047473722.SGD","LU0661504455.SGD","LU1104425308.USD","LU0857590862.USD","LU0964806797.USD","LU1880407132.USD","LU0823399737.USD","SG9999013999.USD","LU0171293334.USD","LU1941712348.USD","SG9999001440.SGD","LU0006306889.USD","LU0196878994.USD","LU1003076772.USD","LU1057294990.SGD","LU2091194634.USD","LU2539964713.USD","LU0949170426.SGD","LU0868494617.USD","BK5011","LU1934455277.USD","LU2324357040.USD","LU2108987350.USD","LU1078025761.USD","BK4585","LU0238689110.USD","LU0265550946.USD","LU1941712264.USD","LU2089284900.SGD","LU2279689827.SGD","LU0526926950.USD","LU1037948897.HKD","LU0234572021.USD","LU2237443622.USD","LU1153584641.USD","LU0499090636.EUR","SG9999014567.USD","LU1019632923.USD","LU2148510915.USD","BK0239","LU0320765489.SGD","LU0203345920.USD","LU1064131003.USD","SG9999001176.SGD","LU2491049909.HKD","LU0128525929.USD","LU0211331839.USD","LU0757432116.USD","SG9999015358.SGD","BK1161","LU0557290698.USD","LU0963555726.SGD","LU1066051225.USD","LU0882574055.USD","LU1571399168.USD","LU2114397693.USD","LU1355424745.HKD","IE00BLSP4452.SGD","LU1153585028.USD","LU0345777659.USD","LU0211326839.USD","LU0997586515.USD","LU1974910355.USD","LU1989771016.USD","LU1046234339.USD","LU1481600234.SGD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637133490","title":"Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2637133490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637133490?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:05","pubTimestamp":1779372321,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical reported a prespecified interim analysis showing its Phase III OptiTROP-Breast03 study of sacituzumab tirumotecan met the primary endpoint of delaying disease worsening versus chemotherapy as a first-line treatment for unresectable locally recurrent or metastatic triple-negative breast cancer.Overall survival results have not been presented in a mature form yet, with a favorable trend seen so far.No new safety issues emerged, supporting continued development in the first-line setting.The readout positions the drug for potential label expansion beyond its existing China approval in later-line triple-negative breast cancer, with regulatory discussions planned with China’s drug regulator on next steps.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7R5dDh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121194992","title":"SKB BIO Shares Surge Over 5% on Positive Phase III Results for TROP2 ADC Developed with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=1121194992","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121194992?lang=en_us&edition=fundamental","pubTime":"2026-05-21 11:05","pubTimestamp":1779332707,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) rose more than 5%. As of press time, the stock was up 3.3%, trading at HK$451.4 with a turnover of HK$166 million. Recently, according to an announcement from SKB BIO, Merck announced...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","LU0432979614.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0130102774.USD","LU0265550359.USD","BK4231","BK4588","LU0985320562.USD","LU1061106388.HKD","LU2125154778.USD","LU2361044949.HKD","BK4585","LU1989772840.SGD","BK4080","LU1201861249.SGD","LU0196878994.USD","LU0868494617.USD","LU1069347547.HKD","LU1066051225.USD","SG9999014567.USD","LU2089984988.USD","LU1989771016.USD","SG9999014559.SGD","LU0234572021.USD","BK4550","LU0203345920.USD","LU0289739699.SGD","LU1066053197.SGD","LU2468319806.SGD","LU2491050154.USD","BK4533","LU0965509010.AUD","IE00BJT1NW94.SGD","SG9999001176.USD","SG9999002224.SGD","LU1941712264.USD","LU2023250843.SGD","LU0942090050.USD","LU2112291526.USD","LU0130517989.USD","LU0861579265.USD","IE000M9KFDE8.USD","SG9999001440.SGD","LU0965508806.USD","LU1941712348.USD","LU2361044865.SGD","IE0009355771.USD","LU1571399168.USD","LU2361045086.USD","BK4007","LU2125154935.USD","LU1023059063.AUD","LU1093756168.USD","SG9999014542.SGD","LU1923622614.USD","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU2324357040.USD","BK4134","LU0320765646.SGD","LU0070302665.USD","SG9999014575.USD","LU2125909593.SGD","BK4534","LU0868494708.USD","LU0122379950.USD","IE00B1BXHZ80.USD","LU1116320737.USD","LU1116320901.HKD","IE00BLSP4239.USD","LU1035773651.USD","LU0965509101.SGD","LU0266013472.USD","LU0265550946.USD","SG9999015358.SGD","SG9999001176.SGD","BK4516","LU0058720904.USD","LU2125909247.SGD","LU1974910355.USD","LU1585245621.USD","LU0477156953.USD","LU2433249047.HKD","IE00BBT3K403.USD","BK1161","LU0238689110.USD","LU1430594728.SGD","LU2357627491.SGD","SG9999002232.USD","SG9999013999.USD","LU1037948541.HKD","SG9999015341.SGD","LU0211331839.USD","LU1066051498.USD","LU1929549753.HKD","LU0965509283.SGD","LU1093756325.SGD","06990","LU2023250504.SGD","LU1934455194.USD","LU2461242641.AUD","MRK","LU1989772923.USD","LU0980610538.SGD","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","IE0002141913.USD","LU2491049909.HKD","LU0859254822.USD","LU2491050071.SGD","LU0320765489.SGD","LU1037948897.HKD","BK4559","LU1934455277.USD","SGXZ57979304.SGD","IE00BSNM7G36.USD","LU1983299246.USD","LU2360032135.SGD","LU1162221912.USD","LU0106261372.USD","LU0098860793.USD","LU0006306889.USD","LU1066051811.HKD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1699723380.USD","LU1917777945.USD","LU0208291251.USD","LU1934455863.HKD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133296679","title":"Stock Track | SKB BIO Soars 5.22% Intraday on Positive Phase III Trial Results and Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1133296679","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133296679?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:54","pubTimestamp":1779328497,"startTime":"0","endTime":"0","summary":"SKB BIO's stock surged 5.22% during intraday trading on Thursday, driven by positive clinical developments and regulatory progress.The rally was fueled by Merck's announcement that sacituzumab...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107878773","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.52% in Regular Trading, TROP2 ADC Phase III Trial Achieves Dual Primary Endpoints in Endometrial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1107878773","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107878773?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:52","pubTimestamp":1779328366,"startTime":"0","endTime":"0","summary":"On May 21, Kelun-Biotech Biopharmaceutical rose 3.52% in regular trading, trading at 454.6 HKD/share, with trading volume of approximately 51.11 million HKD. The rally was driven by continued...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636899669","title":"A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After New Oncology Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899669","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899669?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:40","pubTimestamp":1779237629,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is back in focus after fresh oncology pipeline news, including priority review for sacituzumab tirumotecan in lung cancer and clinical trial approval for bispecific antibody SKB118 in advanced solid tumors.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThese oncology updates come after a mixed stretch for the stock. A 1-day share price return of 1.27% lifted the HK$429.6 quote, but the 30-day share price return is down...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-sehk6990","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-sehk6990","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4581","BK4588","06990","XBI","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145380915","title":"SKB BIO Shares Surge Over 5% in Morning Session on Merck's TROP2 ADC Therapy Phase 3 Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1145380915","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145380915?lang=en_us&edition=fundamental","pubTime":"2026-05-19 09:41","pubTimestamp":1779154861,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) rose more than 5% in morning trading. At the time of writing, the stock was up 4.71% to HK$444.2, with a turnover of HK$38.44 million. The move follows an announcement from Merck that...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015358.SGD","LU0234572021.USD","BK1161","BK4007","BK4231","LU0942090050.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU1066053197.SGD","IE0009355771.USD","SG9999002232.USD","LU1934455277.USD","06990","IE00BSNM7G36.USD","LU0965509101.SGD","LU1699723380.USD","BK4550","LU1037948541.HKD","LU0130102774.USD","LU0859254822.USD","LU1989772923.USD","BK4516","LU2112291526.USD","LU2491049909.HKD","LU0320765489.SGD","LU2361045086.USD","LU1983299246.USD","LU0266013472.USD","LU1571399168.USD","LU1974910355.USD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU0106261372.USD","LU2461242641.AUD","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","BK4534","LU0070302665.USD","LU0861579265.USD","LU2357627491.SGD","LU0868494617.USD","LU0238689110.USD","LU1923622614.USD","LU0122379950.USD","SG9999014542.SGD","LU0965508806.USD","BK4533","LU1585245621.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU2125909247.SGD","LU0130517989.USD","BK4559","LU1934455863.HKD","LU1023059063.AUD","LU1035773651.USD","LU1201861249.SGD","LU1941712348.USD","SG9999001440.SGD","LU0006306889.USD","LU0965509283.SGD","LU1061106388.HKD","LU2125154778.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU0265550359.USD","LU0203347892.USD","LU1057294990.SGD","LU0648001328.SGD","LU1116320901.HKD","LU0980610538.SGD","LU2023250504.SGD","SG9999014559.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","LU2023250843.SGD","BK4585","SG9999002224.SGD","BK4588","IE0002141913.USD","BK4080","LU1989771016.USD","SGXZ57979304.SGD","LU0985320562.USD","LU1162221912.USD","LU0320765646.SGD","LU1093756168.USD","LU1069347547.HKD","IE00B2B36J28.USD","LU1430594728.SGD","LU0098860793.USD","LU0058720904.USD","SG9999014575.USD","LU1941712264.USD","LU0211331839.USD","LU1291159041.SGD","LU2361044865.SGD","LU0265550946.USD","LU2324357040.USD","LU0196878994.USD","LU1066051225.USD","LU1934455194.USD","LU1989772840.SGD","LU2106854487.HKD","LU2125909593.SGD","LU2360032135.SGD","LU2433249047.HKD","LU1066051498.USD","LU0477156953.USD","SG9999014567.USD","SG9999015341.SGD","LU1093756325.SGD","LU2125154935.USD","LU0203345920.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU0965509010.AUD","LU1037948897.HKD","LU1917777945.USD","SG9999001176.USD","LU1066051811.HKD","LU2089984988.USD","LU2361044949.HKD","IE00BN8TJ469.HKD","LU1116320737.USD","LU1929549753.HKD","SG9999013999.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635189272","title":"Sichuan Kelun-Biotech Biopharmaceutical Receives NMPA Approval For IND Application For SKB118 (CR-001)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635189272","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635189272?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:03","pubTimestamp":1778652206,"startTime":"0","endTime":"0","summary":"May 13 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd <6990.HK>::*RECEIVES NMPA APPROVAL FOR IND APPLICATION FOR SKB118 (CR-001) FOR ADVANCED SOLID TUMORS*Further company coverage: 6990.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nRSDbtT8rv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1934453819.USD","LU2148510915.USD","06990","LU1064130708.USD","BK0239","BK0060","LU0196878994.USD","LU1979443071.USD","LU1064131003.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227068","title":"Sichuan Kelun-Biotech Wins China IND Nod for Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227068","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227068?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:57","pubTimestamp":1778637426,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  received approval from China's National Medical Products Administration for the investigational new drug application of SKB118, according to a Wednesday Hong Kong bourse filing.The company said the PD-1/VEGF bispecific antibody is intended for the treatment of advanced solid tumors.The approval clears the company to begin clinical trials for the drug candidate in China, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0196878994.USD","BK1161","BK4588","BK4585","06990","BK4581","XBI","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158310498","title":"SKB BIO Receives NMPA Approval for Investigational New Drug Application of SKB118","url":"https://stock-news.laohu8.com/highlight/detail?id=1158310498","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158310498?lang=en_us&edition=fundamental","pubTime":"2026-05-13 08:04","pubTimestamp":1778630686,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) has announced that it has received a clinical trial notification from the Center for Drug Evaluation of the National Medical Products Administration. The notification grants approval...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162503034","title":"SKB BIO Secures NMPA Green Light for PD-1/VEGF Bispecific Antibody SKB118; Crescent Biopharma Collaboration Advances Global Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1162503034","media":"Bulletin Express","labels":["corporation","productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162503034?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:43","pubTimestamp":1778629386,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO; 06990) has obtained Investigational New Drug (IND) approval from China’s National Medical Products Administration (NMPA) for SKB118...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635922949","title":"Kelun-Biotech says China regulator clears SKB118 clinical trial application","url":"https://stock-news.laohu8.com/highlight/detail?id=2635922949","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635922949?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:32","pubTimestamp":1778628733,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical received China NMPA clearance for an IND to start clinical trials of PD-1xVEGF bispecific antibody SKB118  in advanced solid tumors.Crescent Biopharma granted Kelun-Biotech exclusive rights in Greater China to develop, manufacture, and commercialize SKB118 under a strategic cooperation reached in December 2025.Crescent previously secured US FDA IND clearance in January 2026 to launch global Phase 1/2 ASCEND study in locally advanced or metastatic solid tumors, with planned enrollment of 290 patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Servic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL5rThZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU1064131003.USD","LU1934453819.USD","LU0196878994.USD","BK0239","002422","BK1161","BK0060","LU2148510915.USD","LU1064130708.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635229126","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Receives Nmpa Approval for Ind Application for Skb118 (Cr-001) for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2635229126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635229126?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:32","pubTimestamp":1778628724,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633945936","title":"SKB Biopharma's Application for New Indication of Tumor Drug Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2633945936","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633945936?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:40","pubTimestamp":1778244014,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical's  new indication application for sacituzumab tirumotecan was accepted for review by China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The application is for the drug in combination with pembrolizumab as first-line treatment for adult patients with locally advanced or metastatic non-small cell lung cancer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633437933","title":"the Snda for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Pembrolizumab as First‑Line Treatment for Pd-L1-Positive Nsclc Accepted for Review by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2633437933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633437933?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:40","pubTimestamp":1778236827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUA4WS7GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150179988","title":"SKB BIO's Core TROP2 ADC Therapy Sac-TMT Gains NMPA Acceptance for New Indication Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1150179988","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150179988?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:22","pubTimestamp":1778235723,"startTime":"0","endTime":"0","summary":"Kelun-Bota Biopharma (06990) has announced that a new supplemental New Drug Application (sNDA) for its TROP2-targeting antibody-drug conjugate (ADC), sacituzumab govitecan (sac-TMT, also known as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK4231","LU0196878994.USD","ADC","BK4080","BK1161","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633434014","title":"Kelun-Biotech sac-TMT plus Keytruda NSCLC application accepted for review by China regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2633434014","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633434014?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:14","pubTimestamp":1778235247,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech new indication application for TROP2 ADC sacituzumab tirumotecan  with Merck’s pembrolizumab accepted for review by China NMPA.Filing targets first-line treatment of adult patients with locally advanced or metastatic NSCLC with PD-L1 TPS ≥1%, EGFR-negative, ALK-negative.CDE placed application into priority review and approval process, potentially accelerating clearance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL7gXcRR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","LU1979443071.USD","LU0196878994.USD","002422","06990","LU1934453819.USD","BK0239","LU1064130708.USD","LU1064131003.USD","BK1161","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633343406","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nmpa Accepts New Indication Application for Sacituzumab Tirumotecan (Sac-TMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633343406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633343406?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:14","pubTimestamp":1778235240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nFWN41L0D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632947746","title":"3 Asian Stocks That May Be Undervalued In May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2632947746","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632947746?lang=en_us&edition=fundamental","pubTime":"2026-05-01 12:08","pubTimestamp":1777608485,"startTime":"0","endTime":"0","summary":"As global markets navigate geopolitical tensions and economic shifts, Asian equities have shown resilience, with some indices stabilizing amid mixed performances across major regions. In this environment of cautious optimism and strategic positioning, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on market inefficiencies.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9621091-choice2-main-header/1585186855318","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621091-choice2-main-header/1585186855318"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/tw/tech/twse-2301/lite-on-technology-shares/news/3-asian-stocks-that-may-be-undervalued-in-may-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/tw/tech/twse-2301/lite-on-technology-shares/news/3-asian-stocks-that-may-be-undervalued-in-may-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154953853","title":"SKB BIO Shares Rise Nearly 3% in Late Trading as Three Studies Selected for Oral Presentation at 2026 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1154953853","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154953853?lang=en_us&edition=fundamental","pubTime":"2026-04-24 15:40","pubTimestamp":1777016441,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) saw its shares climb nearly 3% in late trading. At the time of writing, the stock was up 2.24%, trading at HK$475, with a turnover of HK$235 million. The 2026 American Society of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","BK4588","VXUS","BK4585","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}